About Dhiren Thakker
Form D filings for Med Aditus Pharmaceuticals in 2024 list Dhiren Thakker as president and CEO, director.
Dhiren Thakker first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Dhiren Thakker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dhiren Thakker works with at each company, as listed on that company's latest Form D.
Med Aditus Pharmaceuticals, Inc. · Form D, Nov 6, 2024